STRS Ohio’s Adicet Bio ACET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-300
Closed -$49K 2227
2021
Q2
$49K Buy
+300
New +$61.1K ﹤0.01% 2110
2019
Q2
Sell
-17
Closed -$12K 2107
2019
Q1
$12K Hold
17
﹤0.01% 1996
2018
Q4
$16K Hold
17
﹤0.01% 2003
2018
Q3
$28K Hold
17
﹤0.01% 2004
2018
Q2
$17K Hold
17
﹤0.01% 2067
2018
Q1
$18K Buy
+17
New +$31.2K ﹤0.01% 1821

Other funds holding ACET

STRS Ohio's ACET Position: Q3 2021 in Review

STRS Ohio sold out of Adicet Bio (ACET) in Q3 2021, closing a stake of 300 shares — an estimated $49K sold.

STRS Ohio first reported a position in ACET in Q1 2018 and held it in 6 quarters. The position peaked at $49K in Q2 2021. 58 funds tracked by Wall St. Rank hold ACET as of Q3 2021.

  • STRS Ohio reported no remaining Adicet Bio position as of Q3 2021 after selling out during the quarter.
  • STRS Ohio sold 300 Adicet Bio shares in Q3 2021, an estimated $49K.
  • STRS Ohio first reported a position in Adicet Bio in Q1 2018 and held it in 6 quarters.
  • STRS Ohio's Adicet Bio position peaked at $49K in Q2 2021.
  • 58 funds tracked by Wall St. Rank held Adicet Bio as of Q3 2021.

Based on STRS Ohio's 13F filing for Q3 2021, filed 22 Oct 2021.